main content start
About Us
ADA Newsroom
Get the latest news from ADA, including press releases and research announcements.
Press Releases
If you are looking for ADA press releases issued prior to 2019, please email press@.
Recent Press release
Local Press Release
The American Diabetes Association Announces State of Diabetes in Chicago
Panelists to Discuss Obesity, Diabetes, and Health Care
Local Press Release
The American Diabetes Association Announces State of Diabetes in East Brunswick, New Jersey
Panelists to Discuss Diabetes, Obesity, and the Cost of…
Local Press Release
The American Diabetes Association Announces State of Diabetes in Indiana
Panelists to discuss addressing the cost of diabetes and
Official Statement
Recent Press release
Local Press Release
The American Diabetes Association Announces State of Diabetes in Chicago
Panelists to Discuss Obesity, Diabetes, and Health Care
Local Press Release
The American Diabetes Association Announces State of Diabetes in East Brunswick, New Jersey
Panelists to Discuss Diabetes, Obesity, and the Cost of…
Local Press Release
The American Diabetes Association Announces State of Diabetes in Indiana
Panelists to discuss addressing the cost of diabetes and
Local Press Releases
Recent Press release
Local Press Release
The American Diabetes Association Announces State of Diabetes in Chicago
Panelists to Discuss Obesity, Diabetes, and Health Care
Local Press Release
The American Diabetes Association Announces State of Diabetes in East Brunswick, New Jersey
Panelists to Discuss Diabetes, Obesity, and the Cost of…
Local Press Release
The American Diabetes Association Announces State of Diabetes in Indiana
Panelists to discuss addressing the cost of diabetes and
Press release
Canagliflozin Shown to Improve Cardiovascular and Renal Outcomes in People with Type 2 Diabetes and Kidney Disease
For people with type 2 diabetes (T2D) and chronic kidney disease (CKD), canagliflozin, an oral, sodium-glucose co-transporter-2 (SGLT2)
Press release
Oral Semaglutide Reduces Occurrence of Major Cardiac Events in People with Type 2 Diabetes With High Cardiovascular Risk
Results of the PIONEER 6 trial indicate oral semaglutide is safe for patients with type 2 diabetes (T2D) at high cardiovascular (CV) risk…
Press release
Dapagliflozin Reduces Progression of Kidney Disease and Renal Death in People with Type 2 Diabetes
The first sub-analysis of renal data from the Dapagliflozin Effect on Cardiovascular Events Thrombolysis In Myocardial Infarction (…
Meet Our Experts
The American Diabetes Association is proud to partner with leading experts in the field of diabetes—each one directed to advancing the treatment and prevention of this disease.
Charles D. Henderson
Chief Executive Officer
Robert Gabbay, MD, PhD
Chief Scientific and Medical Officer
Lisa Murdock
Chief Advocacy Officer
Nuha El Sayed, MD, MMSc
Senior Vice President, Health Care Improvement
Marlon Pragnell, PhD
Vice President, Research & Science
Crystal Woodward, MPS
Managing Director, Legal Advocacy/Safe at School
Give Today and Change lives!
With your support, the American Diabetes Association® can continue our lifesaving work to make breakthroughs in research and provide people with the resources they need to fight diabetes.